BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 38323313)

  • 1. Tumor cell senescence-induced macrophage CD73 expression is a critical metabolic immune checkpoint in the aging tumor microenvironment.
    Deng Y; Chen Q; Yang X; Sun Y; Zhang B; Wei W; Deng S; Meng J; Hu Y; Wang Y; Zhang Z; Wen L; Huang F; Wan C; Yang K
    Theranostics; 2024; 14(3):1224-1240. PubMed ID: 38323313
    [No Abstract]   [Full Text] [Related]  

  • 2. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy.
    Liu X; Si F; Bagley D; Ma F; Zhang Y; Tao Y; Shaw E; Peng G
    J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36192086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications.
    Zhao B; Wu B; Feng N; Zhang X; Zhang X; Wei Y; Zhang W
    J Hematol Oncol; 2023 Mar; 16(1):28. PubMed ID: 36945046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various Cancers.
    Tang K; Zhang J; Cao H; Xiao G; Wang Z; Zhang X; Zhang N; Wu W; Zhang H; Wang Q; Xu H; Cheng Q
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophages and tumor-associated macrophages in the senescent microenvironment: From immunosuppressive TME to targeted tumor therapy.
    Du M; Sun L; Guo J; Lv H
    Pharmacol Res; 2024 Apr; 204():107198. PubMed ID: 38692466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies.
    D'Ambrosio M; Gil J
    Dev Cell; 2023 Jun; 58(12):1007-1021. PubMed ID: 37339603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism drives macrophage heterogeneity in the tumor microenvironment.
    Li S; Yu J; Huber A; Kryczek I; Wang Z; Jiang L; Li X; Du W; Li G; Wei S; Vatan L; Szeliga W; Chinnaiyan AM; Green MD; Cieslik M; Zou W
    Cell Rep; 2022 Apr; 39(1):110609. PubMed ID: 35385733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent state.
    Matsuda S; Revandkar A; Dubash TD; Ravi A; Wittner BS; Lin M; Morris R; Burr R; Guo H; Seeger K; Szabolcs A; Che D; Nieman L; Getz GA; Ting DT; Lawrence MS; Gainor J; Haber DA; Maheswaran S
    Cell Rep; 2023 Mar; 42(3):112129. PubMed ID: 36821441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A2AR-mediated CXCL5 upregulation on macrophages promotes NSCLC progression via NETosis.
    Lei Q; Zhen S; Zhang L; Zhao Q; Yang L; Zhang Y
    Cancer Immunol Immunother; 2024 Apr; 73(6):108. PubMed ID: 38642131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral CD73: An immune checkpoint shaping an inhibitory tumor microenvironment and implicating poor prognosis in Chinese melanoma cohorts.
    Gao Z; Wang L; Song Z; Ren M; Yang Y; Li J; Shen K; Li Y; Ding Y; Yang Y; Zhou Y; Wei C; Gu J
    Front Immunol; 2022; 13():954039. PubMed ID: 36131912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senescence and Immunotherapy: Redundant Immunomodulatory Pathways Promote Resistance.
    Oesterreich S; Aird KM
    Cancer Immunol Res; 2023 Apr; 11(4):401-404. PubMed ID: 36826438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genes associated with cellular senescence favor melanoma prognosis by stimulating immune responses in tumor microenvironment.
    Liang X; Lin X; Lin Z; Lin W; Peng Z; Wei S
    Comput Biol Med; 2023 May; 158():106850. PubMed ID: 37031510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
    Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and experimental validation of a macrophage cell senescence-related gene signature to evaluate the prognosis, immunotherapeutic sensitivity, and chemotherapy response in bladder cancer.
    Jiang Q; Zhou J; Chen Q; Huang Y; Yang C; Liu C
    Funct Integr Genomics; 2023 Jul; 23(3):228. PubMed ID: 37423913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD73 in small extracellular vesicles derived from HNSCC defines tumour-associated immunosuppression mediated by macrophages in the microenvironment.
    Lu T; Zhang Z; Zhang J; Pan X; Zhu X; Wang X; Li Z; Ruan M; Li H; Chen W; Yan M
    J Extracell Vesicles; 2022 May; 11(5):e12218. PubMed ID: 35524455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity.
    Piovesan D; Tan JBL; Becker A; Banuelos J; Narasappa N; DiRenzo D; Zhang K; Chen A; Ginn E; Udyavar AR; Yin F; Paprcka SL; Purandare B; Park TW; Kimura N; Kalisiak J; Young SW; Powers JP; Schindler U; Sivick KE; Walters MJ
    Mol Cancer Ther; 2022 Jun; 21(6):948-959. PubMed ID: 35405741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of tumor-associated macrophages inhibits lung cancer growth and enhances the antitumor effect of cisplatin.
    Kawaguchi Y; Ohshio Y; Watanabe A; Shiratori T; Okamoto K; Ueda K; Kataoka Y; Suzuki T; Hanaoka J
    Cancer Sci; 2023 Mar; 114(3):750-763. PubMed ID: 36411518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma.
    Xu W; Wu Y; Liu W; Anwaier A; Tian X; Su J; Huang H; Wei G; Qu Y; Zhang H; Ye D
    Int J Biol Sci; 2022; 18(13):4884-4900. PubMed ID: 35982911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.